drugset / Trial / NCT00924222

Organ Protection With Sevoflurane Postconditioning After Cardiac Surgery With Cardiopulmonary Bypass

NCT00924222 ↗

Completed 120 enrolled University of Zurich
RandomizedParallel-groupOpen-labelTreatment

Summary

Organ protection, volatile anesthetics, postconditioning. Sedation of patients on ICU after cardiac surgery with cardiopulmonary bypass with either propofol or sevoflurane. Evaluation of organ function and inflammatory mediators in the blood.

Timeline

Start
2007-10
Primary completion
2009-11
Completion
2009-12

Outcome

Met primary endpoint

paper troponin T as the most sensitive marker for myocardial injury at POD1 was significantly lower in the sevoflurane group compared with the propofol group PMID 23062276 ↗

paper unadjusted difference, -0.4; 95% CI, -0.7 to -0.1; P < 0.01 PMID 23062276 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule — —
Subject Sevoflurane Other / unclassified — —

Indications

No indication recorded.